United-Guardian Declares Quarterly Dividend, Highlights Growth Initiatives

United-Guardian ( (UG) ) has shared an update.

On January 26, 2026, the board of United-Guardian, Inc. declared a cash dividend of $0.25 per share, marking the 31st consecutive year the company has paid a dividend, with payment scheduled for February 17, 2026 to shareholders of record as of February 9, 2026. The company’s leadership emphasized that the dividend is consistent with its prior payout and reflects a strategy that balances earnings, growth initiatives, and shareholder interests, while highlighting new distribution agreements, ongoing development of personal care products, and a refreshed marketing push for Renacidin as factors expected to support future improvements in sales and earnings.

The most recent analyst rating on (UG) stock is a Buy with a $7.00 price target. To see the full list of analyst forecasts on United-Guardian stock, see the UG Stock Forecast page.

Spark’s Take on UG Stock

According to Spark, TipRanks’ AI Analyst, UG is a Outperform.

The score is primarily driven by strong financial quality (notably zero debt and healthy margins), supported by reasonable valuation and a very high dividend yield. These positives are moderated by weakening recent fundamentals (TTM revenue and free cash flow declines) and a still-soft technical trend (below key longer-term moving averages and negative MACD).

To see Spark’s full report on UG stock, click here.

More about United-Guardian

United-Guardian, Inc., based in Hauppauge, N.Y., is a manufacturer of personal care, cosmetic, and sexual wellness ingredients, as well as pharmaceuticals and medical lubricants, with a key focus on its Renacidin-branded pharmaceutical product and distribution in multiple territories.

Average Trading Volume: 11,671

Technical Sentiment Signal: Sell

Current Market Cap: $30.46M

See more data about UG stock on TipRanks’ Stock Analysis page.